Health
Bristol Myers Squibb Introduces "Change the Target. Change What’s Possible." to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care
PRINCETON, N.J., February 03, 2026--Bristol Myers Squibb Introduces "Change the Target. Change What’s Possible." to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care
About this update from Bristol-myers Squibb Company
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1497,"height":206,"url":"https://media.zenfs.com/en/business-wire.com/facdbec908ef0d232f2abce37c9da87e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6bqIZrX9IlafWhHw0ltNhQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTEzMjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/facdbec908ef0d232f2abce37c9da87e","width":960,"height":132},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/i7kN.z9pr0B97E.ynN8FCA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zMzA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/facdbec908ef0d232f2abce37c9da87e","width":1200,"height":165}},"lazy":false},{"type":"text","content":"Cardiovascular and thromboembolic diseases are among the leading causes of death and disability, accounting for nearly 1 million deaths in the U.S. annually","length":156,"tagName":"p","attribs":{}},{"type":"text","content":"Clinician-focused educational program, developed in partnership with Johnson & Johnson, highlights care for patients at high risk of thromboembolic events such as stroke, and the emerging potential of factor XIa (FXIa) research to meet unmet needs","length":251,"tagName":"p","attribs":{}},{"type":"text","content":"PRINCETON, N.J., February 03, 2026--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) announced today the launch of "Change the Target. Change What’s Possible." an educational campaign developed in partnership with Johnson & Johnson for clinicians who manage cardiovascular and thromboembolic conditions. The program spotlights the unmet need in cardiovascular care for patients who, despite currently available therapies, remain at high risk of thromboembolic events, underscoring the need for new innovations to help address one of the leading causes of death and disability in the U.S. The unmet need is significant - 40% of patients with atrial fibrillation are untreated or undertreated, and roughly 25% of strokes are recurrent, many of which are considered preventable - with potential bleeding risks contributing to gaps in protection.","length":857,"tagName":"p"},{"type":"text","content":""With heart disease and stroke among the leading causes of death and disability worldwide, it is imperative to continue research in preventing these events," ...